Development and evaluation of a recombinant VP2 neutralizing epitope antigen vaccine candidate for infectious bursal disease virus

2021 ◽  
Author(s):  
Xiaochen Guo ◽  
Wenying Sun ◽  
Lan Wei ◽  
Xiangxiang Wang ◽  
Yimeng Zou ◽  
...  
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Vaccine Candidate ◽  
Infectious Bursal Disease ◽  
Neutralizing Epitope ◽  
Antigen Vaccine ◽  
Bursal Disease

Recombinant VP2 expressed in baculovirus and adjuvanted with TIR-TLR7: a vaccine candidate against infectious bursal disease virus

2018 ◽  
Vol 27 (4) ◽  
pp. 911-916 ◽  
Author(s):  
Mohammad Majid Ebrahimi ◽  
Shahla Shahsavandi ◽  
Parviz Shayan ◽  
Hossein Goudarzi ◽  
Shahin Masoudi
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Vaccine Candidate ◽  
Infectious Bursal Disease ◽  
Bursal Disease

A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virus

Vaccine ◽  
2014 ◽  
Vol 32 (13) ◽  
pp. 1436-1443 ◽  
Author(s):  
Xiaole Qi ◽  
Yuming Chen ◽  
Xiangang Ren ◽  
Lizhou Zhang ◽  
Li Gao ◽  
...  
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Vaccine Candidate ◽  
Infectious Bursal Disease ◽  
Bursal Disease

A reassortment vaccine candidate of the novel variant infectious bursal disease virus

2020 ◽  
Vol 251 ◽  
pp. 108905
Author(s):  
Linjin Fan ◽  
Yulong Wang ◽  
Nan Jiang ◽  
Li Gao ◽  
Kai Li ◽  
...  
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Vaccine Candidate ◽  
Infectious Bursal Disease ◽  
The Novel ◽  
Bursal Disease ◽  
Novel Variant

Modified activity of a VP2-located neutralizing epitope on various vaccine, pathogenic and hypervirulent strains of infectious bursal disease virus

1997 ◽  
Vol 142 (2) ◽  
pp. 255-270 ◽  
Author(s):  
N. Eterradossi ◽  
D. Toquin ◽  
G. Rivallan ◽  
M. Guittet
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Infectious Bursal Disease ◽  
Neutralizing Epitope ◽  
Bursal Disease

scholarly journals Development of a Viral-Like Particle Candidate Vaccine Against Novel Variant Infectious Bursal Disease Virus

Vaccines ◽  
2021 ◽  
Vol 9 (2) ◽  
pp. 142
Author(s):  
Yulong Wang ◽  
Nan Jiang ◽  
Linjin Fan ◽  
Li Gao ◽  
Kai Li ◽  
...  
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Protective Efficacy ◽  
Expression System ◽  
Size Exclusion ◽  
Candidate Vaccine ◽  
Infectious Bursal Disease ◽  
Immune Protection ◽  
Bursal Disease ◽  
Novel Variant

Infectious bursal disease (IBD), an immunosuppressive disease of young chickens, is caused by infectious bursal disease virus (IBDV). Novel variant IBDV (nVarIBDV), a virus that can evade immune protection against very virulent IBDV (vvIBDV), is becoming a threat to the poultry industry. Therefore, nVarIBDV-specific vaccine is much needed for nVarIBDV control. In this study, the VP2 protein of SHG19 (a representative strain of nVarIBDV) was successfully expressed using an Escherichia coli expression system and further purified via ammonium sulfate precipitation and size-exclusion chromatography. The purified protein SHG19-VP2-466 could self-assemble into 25-nm virus-like particle (VLP). Subsequently, the immunogenicity and protective effect of the SHG19-VLP vaccine were evaluated using animal experiments, which indicated that the SHG19-VLP vaccine elicited neutralization antibodies and provided 100% protection against the nVarIBDV. Furthermore, the protective efficacy of the SHG19-VLP vaccine against the vvIBDV was evaluated. Although the SHG19-VLP vaccine induced a comparatively lower vvIBDV-specific neutralization antibody titer, it provided good protection against the lethal vvIBDV. In summary, the SHG19-VLP candidate vaccine could provide complete immune protection against the homologous nVarIBDV as well as the heterologous vvIBDV. This study is of significance to the comprehensive prevention and control of the recent atypical IBD epidemic.

Antox® and Bactofort® mitigated the haematological alterations induced by a very virulent infectious bursal disease virus in chicks

2021 ◽  
Author(s):  
Aliyu Danlami Andamin ◽  
Paul Ayuba Abdu ◽  
Felix Tersua Akade ◽  
Ochuko Orakpoghenor ◽  
Tagang Aluwong
Keyword(s):  
Disease Virus ◽  
Infectious Bursal Disease Virus ◽  
Infectious Bursal Disease ◽  
Bursal Disease

scholarly journals Chicken Heat Shock Protein 70 Is an Essential Host Protein for Infectious Bursal Disease Virus Infection In Vitro

Pathogens ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 664
Author(s):  
Yufang Meng ◽  
Xiaoxue Yu ◽  
Chunxue You ◽  
Wenjuan Zhang ◽  
Yingfeng Sun ◽  
...  
Keyword(s):  
Heat Shock ◽  
Heat Shock Protein ◽  
Disease Virus ◽  
Heat Shock Protein 70 ◽  
Infectious Bursal Disease Virus ◽  
Host Protein ◽  
Infectious Bursal Disease ◽  
Economic Losses ◽  
Small Interfering Rnas ◽  
Bursal Disease

Infectious bursal disease virus (IBDV) infection causes pathogenicity and mortality in chickens, leading to huge economic losses in the poultry industry worldwide. Studies of host-virus interaction can help us to better understand the viral pathogenicity. As a highly conservative host factor, heat shock protein 70 (Hsp70) is observed to be involved in numerous viral infections. However, there is little information about the role of chicken Hsp70 (cHsp70) in IBDV infection. In the present study, the increased expression of cHsp70 was observed during IBDV-infected DF-1 cells. Further studies revealed that Hsp70 had similar locations with the viral double-stranded RNA (dsRNA), and the result of pull-down assay showed the direct interaction between cHsp70 with dsRNA, viral proteins (vp)2 and 3, indicating that maybe cHsp70 participates in the formation of the replication and transcription complex. Furthermore, overexpression of cHsp70 promoted IBDV production and knockdown of cHsp70 using small interfering RNAs (siRNA) and reducedviral production, implying the necessity of cHsp70 in IBDV infection. These results reveal that cHsp70 is essential for IBDV infection in DF-1 cells, suggesting that targeting cHsp70 may be applied as an antiviral strategy.

Sign in / Sign up

Export Citation Format

Share Document